the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Prescription Drugs Market Research Reports

 

Global Information, Inc. offers market intelligence on every topic in the Prescription Drugs Market, including, but not limited to latest trend on: Prescription Drug; Generic Prescription; Prescription Pharmaceuticals.

We offer market research, industry forecasts, and business analysis in the Prescription Drugs Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Antibiotic Resistance and Antibiotic Technologies: Global Markets
Table of Contents Published: 2009/11 Published by: BCC Research
The scope of this report includes current antibiotic markets as well as the emerging antibiotic market, with an exclusive focus on antibiotic resistance. It technically encompasses antibacterials that include antibiotics, bacterial vaccines, and other eme ...

Pharmaceutical Distribution in the US: Current and Future Perspectives
Table of Contents Published: 2009/07 Published by: Urch Publishing, Ltd.
In the US, the pharmaceutical supply chain involves the daily delivery of approximately 13 million prescription products to pharmacies, hospitals, clinics and other healthcare provider locations. ...

Prescription Drugs
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class -Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, An ...

The Chinese Hospital Pharmaceutical Market Outlook To 2014: Policy environment, healthcare system, market structure, competitive landscape, growth opportunities
Table of Contents Published: 2009/07 Published by: Business Insights
The Chinese Hospital Pharmaceutical Market Outlook to 2014' provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and includes detailed epidemiological analyses of the common risk fac ...

Chinese Markets for Antibiotics
Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co.
China' s demand for Antibiotics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply a ...

U.S. Glaucoma Pharmaceuticals Market
Table of Contents Published: 2009/03 Published by: Frost & Sullivan
This research service explores the market for prescription ophthalmics used for the treatment of glaucoma in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and ...

Stakeholder Opinions: Physician perception of biologics in Autoimmune Disease - Targeted detailing is the key to success
Table of Contents Published: 2009/03 Published by: Datamonitor
Factors influencing a prescribing decision can diverge from clinical facts. In the highly competitive autoimmune area, misconceptions and physician habits can result in loss of sales. Targeted detailing of specialist physicians, differentiating by indicat ...

Flomax Case Study: Evolving Disease State Awareness to Succeed with New Method of Action
Table of Contents Published: 2009/02 Published by: Best Practices, LLC
This case study reviews the strategy and tactics utilized by Boehringer-Ingelheim for the BPH (Benign Prostatic Hyperplasia) indicated product, Flomax/Tamsulosin, to differentiate the product and to boost disease awareness to expand the product market. By ...

Women's Health: Worldwide Prescription Drug Markets
Table of Contents Published: 2009/02 Published by: Kalorama Information
Women' s Health: Worldwide Prescription Drug Markets, represents the fourth time that Kalorama Information has tackled the women' s health pharmaceutical market. Revenues from these segments are not reported in total, as certain segments affect both men a ...

Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2009
Table of Contents Published: 2009/01 Published by: Pacific Bridge Medical
This report reviews the orphan drug regulations throughout Asia and discusses various business issues related to orphan drugs in Asia. Lists of approved orphan drugs in Asia and orphan drug associations are also included. ...

The World Dermatological Market Outlook, 2009-2023
Table of Contents Published: 2009/01 Published by: Visiongain
This new market analysis by visiongain is to examine the current and future prospects for the world dermatological market. The world dermatological market generated total sales revenues of over $18bn in 2007. Visiongain predicts that this market area will ...

Women's Health Series: How Have New Oral Contraceptives Changed the Market?
Table of Contents Published: 2008/09 Published by: Decision Resources, Inc.
The oral contraceptive market is mature, with a high level of competition and a stable patient population. Dozens of oral contraceptives are available worldwide; most are comparable in terms of effi cacy in their primary indication (preventing pregnancy) ...

Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals)
Table of Contents Published: 2008/06 Published by: Technical Insights, Inc.
This research service analyzes the emerging trends in cancer therapies with respect to small molecule drugs and biologicals. ...

World Market for Prescription Generic Drugs, 6th Edition
Table of Contents Published: 2008/04 Published by: Kalorama Information
This report provides Global Prescription Generic Drugs Market Research, Trends, Analysis. ...

Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market
Table of Contents Published: 2008/03 Published by: Datamonitor
The opioid market is currently valued at $7.7 billion and is set to increase over the next 10 years at a CAGR of 2.4%. Despite this market being exclusively comprised of old genericized molecules, novel formulations and delivery methods have stimulated gr ...

U.S. Specialty Pharmaceuticals - Overview And Trends
Table of Contents Published: 2007/12 Published by: Frost & Sullivan
This research service was constructed to provide an overview of trends, business models and selected areas of opportunity in specialty pharmaceuticals. ...

Pharmaceutical Product Approval Trends, 2007: Key market benchmarks and strategic insights
Table of Contents Published: 2007/12 Published by: Urch Publishing, Ltd.
Pharmaceutical Product Approval Trends 2007: Key market benchmarks and strategic insights presents a detailed analysis of the new pharmaceutical products approved globally. The 120-page report outlines the key therapeutic markets, significant pharmace ...

Pediatric Drugs: the Worldwide Market, 3rd Edition
Table of Contents Published: 2007/12 Published by: Kalorama Information
Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market. The recognition of the ri ...

The World Market for Prescription Cardiovascular Drugs, 2nd Edition
Table of Contents Published: 2007/12 Published by: Kalorama Information
This report provides World Prescription Cardiovascular Drugs Market Research, Trends, Analysis. ...

SPECIAL REPORT: Blockbusters Then and Now--Trends for Billion-Dollar Drugs
Table of Contents Published: 2007/12 Published by: Decision Resources, Inc.
Small-molecule pharmaceutical manufacturers have had a rough year: 2007 saw the abrupt ending of the development of many highly anticipated blockbuster compounds. ...

Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Table of Contents Published: 2007/11 Published by: Business Insights
This report provides Pharmaceutical Pricing & Reimbursement Market Research, Trends, Analysis. ...

Nicotinic Receptor Agonists for Treating Diseases of Cognitive Dysfunction
Table of Contents Published: 2007/11 Published by: Decision Resources, Inc.
Nicotine has long been known to improve cognitive function, but its adverse effects make it problematic as a treatment for diseases of cognitive dysfunction. Recent research has revealed that certain subtypes of nicotinic acetylcholinesterase receptors (n ...

Prescribing Pharmacists: A Decision Maker Emerges
Table of Contents Published: 2007/10 Published by: Kalorama Information
This report provides Prescribing Pharmacists Market Research, Trends, Analysis. ...

Global Markets for Orphan Drugs
Table of Contents Published: 2007/09 Published by: BCC Research
This report provides Global Orphan Drugs Market Research, Trends, Analysis. ...

Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006
Table of Contents Published: 2007/07 Published by: Datamonitor
This report provides Cancer Therapy Brands Market Research, Trends, Analysis. ...

Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007
Table of Contents Published: 2007/07 Published by: Datamonitor
Female sexual dysfunction (FSD) affects an estimate 84 million women across the seven major pharmaceutical markets and represents a significant opportunity for investment. Despite its high prevalence, FSD is poorly understood and defined. Currently there ...

Parallel Trade - US Lawmakers allow imported prescriptions drugs
Table of Contents Published: 2007/06 Published by: Visiongain
This report will give you the understanding you require to gain that competitive edge in the parallel trade market. ...

Rimonabant: The first of the Cannabinoid blockbusters
Table of Contents Published: 2007/06 Published by: Visiongain
The report provides in-depth market analysis for current and potential products. The report extensively identifies cannabinoid drugs market potential by analysing the latest clinical trial research and highlighting new indications. ...

Prescription Drug Counterfeiting
Table of Contents Published: 2007/04 Published by: Drug & Market Development Publications
This report provides a unique examination and analysis of major global pharmaceutical markets, delivers a realistic description of counterfeiter capabilities, and covers new and emerging anti-counterfeiting technologies ...

Erythromycin, its derivatives: trends and prospects in international trade
Table of Contents Published: 2007/02 Published by: Merchant Research & Consulting LTD.
This report examines international trade and worldwide market trends pertaining to erythromycin and its derivatives. ...

Pricing and Reimbursement Issues in Psychiatry
Table of Contents Published: 2006/12 Published by: Decision Resources, Inc.
Compared with many other disease areas (e.g., cancer, immune diseases), the costs of drug therapy for psychiatric disorders are relatively modest. ...

Herbal Supplements, Prescription Drugs, Rx-to-OTC Products: A Comparison
Table of Contents Published: 2006/10 Published by: BCC Research
This report provides the research about Herbal Supplements, Prescription Drugs, Rx-to-OTC Products Market. ...

The World Market for Prescription Gastrointestinal Drugs
Table of Contents Published: 2006/07 Published by: Kalorama Information
This report provides and in-depth analysis of the market for prescription drugs used in the treatment of gastrointestinal (GI) disorders. ...

Off-Label Prescribing: Overcoming the Reimbursement Barrier
Table of Contents Published: 2006/06 Published by: Decision Resources, Inc.
This report examines the reimbursement barriers to off-label prescribing in the world's six largest pharmaceutical markets: the United States, France, Germany, Italy, the United Kingdom, and Japan. ...

Blockbuster Pharmaceutical Launches: Establishing Market Leadership
Table of Contents Published: 2006/05 Published by: Cutting Edge Information
The blockbuster drug model drove the pharmaceutical industry to great heights for decades. In the current pharmaceutical market, however, blockbusters are becoming few and far between. ...

Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2005
Table of Contents Published: 2006/04 Published by: Decision Resources, Inc.
In the fourth quarter of 2005, governments in several of the world's leading pharmaceutical markets prepared the ground for major reforms to their drug pricing and reimbursement systems. ...

U.S. Anticoagulant Market
Table of Contents Published: 2006/04 Published by: Frost & Sullivan
This Frost & Sullivan research service entitled The U.S. Anticoagulant Market provides an analysis of the following areas: warfarin, heparins, direct thrombin inhibitors, synthetic pentasaccharides, and emerging new mechanism anticoagulants. Major trends ...

Preparing Health Technology Submissions for Pharmaceutical Products
Table of Contents Published: 2006/04 Published by: Urch Publishing, Ltd.
The report considers, in particular, the implications of the standards required in the NICE and WPM guidelines for manufacturers preparing reimbursement submissions ...

The World Market for Prescription Generic Drugs, 5th Edition
Table of Contents Published: 2006/04 Published by: Kalorama Information
The landscape of generic companies is changing: their relative might in the industry is increasing and the product lines their offering are growing in depth and breadth. ...

The Dyslipidemia Market: Can Growth Be Sustained as Statin Patents Expire?
Table of Contents Published: 2006/03 Published by: Decision Resources, Inc.
Dyslipidemia is a key independent risk factor for cardiovascular disease (CVD); CVD is the largest therapeutic segment of the world pharmaceutical market, and treatment of dyslipidemia represents a major sector of the CVD market. ...

The Worldwide Market for Prescription Dermatological Drugs, 5th Edition
Table of Contents Published: 2006/02 Published by: Kalorama Information
This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. ...

Progress Report on the Medicare Prescription Drug Benefit
Table of Contents Published: 2005/12 Published by: Decision Resources, Inc.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (commonly known as the Medicare Modernization Act, or MMA) is arguably the most significant development in U.S. health care policy in recent years. ...

Commercial Insight: Migraine - A Painful Future for the Triptans?
Table of Contents Published: 2004/12 Published by: Datamonitor
Overview of current market including profiles of key brands and key events impacting each brand during 2003-2004 ...

eCompliance - Part 1: The Patient's Perspective
Table of Contents Published: 2004/12 Published by: Datamonitor
This report analyzes the attitudes and preferences of consumers towards the use of eCompliance tools ...

Rigel's Allergic Rhinitis Candidate - R112
Table of Contents Published: 2004/10 Published by: Datamonitor
Summary of potential partners for Rigel, including GSK, Pfizer, Merck, AstraZeneca, Sanofi-Aventis, Schering-Plough, Boehringer Ingelheim and UCB ...

Prescription Drugs: Global Outlook to 2008
Table of Contents Published: 2004/10 Published by: Takeda Pacific
This report is about the global market for prescription drugs and estimates the market outlook to 2008. ...

Pharmaceutical Pricing - Global Perspectives
Table of Contents Published: 2004/09 Published by: Urch Publishing, Ltd.
Pharmaceutical Pricing - Global Perspectives is a strategic report, that analyses all aspects of pharmaceutical pricing and reimbursement strategies through extensive use of case studies. ...

Commercial Insight: Antibacterials - Regulations, Resistance & Generics
Table of Contents Published: 2004/09 Published by: Datamonitor
Antibacterial players are currently facing significant hurdles in terms of increasing and maintaining product revenue. ...

Revolutionary Trends in Cardiovascular Medicine: Diagnostics, Therapeutics and Devices Diagnostics, Therapeutics and Devices
Table of Contents Published: 2004/08 Published by: BCC Research
A comprehensive overview of one category of diagnostics, one category of therapeutics and three categories of devices that are, or will be revolutionizing the treatment of cardiovascular diseases ...

Pipeline Insight: Antihypertensives - Together We Stand, Divided We Fail
Table of Contents Published: 2004/08 Published by: Datamonitor
Analysis of key late stage developmental therapies in the anti-hypertensives market. ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.